Abstracts tagged "Adult-onset Still’s disease"

Abstract Number: 1242 • 2014 ACR/ARHP Annual Meeting
Switching Biologic Agents in Refractory Adult-Onset Still’s Disease: Efficacy and Safety in a Cohort of 20 Patients at a Single Referral Center
Giulio Cavalli¹, Stefano Franchini¹, Corrado Campochiaro¹, Elena Baldissera², Lorenzo Dagna³ and Maria Grazia Sabbadini³, ¹Internal Medicine and Clinical Immunology, Vita-Salute San Raffaele University, Milan, Italy, ²Clinical immunopathology and advanced medical therapeutics, San Raffaele Scientific Institute, Milan, Italy, ³Internal Medicine and Clinical Immunology, Vita-Salute San Raffaele University, Milano, Italy
Background/Purpose No data is available on the long-term clinical outcome of Adult-Onset Still's Disease (AOSD) patients treated with biological drugs, nor on the efficacy and…
Abstract Number: 2028 • 2013 ACR/ARHP Annual Meeting
Efficacy and Safety Of Biologic Agents In Adult-Onset Still’s Disease: A Long-Term Follow-Up Of 19 Patients At a Single Referral Center
Giulio Cavalli^1,2, Stefano Franchini¹, Alvise Berti¹, Corrado Campochiaro¹, Barbara Guglielmi¹, Maria Grazia Sabbadini¹, Elena Baldissera³ and Lorenzo Dagna^4,5, ¹Internal Medicine and Clinical Immunology, Vita-Salute San Raffaele University, Milan, Italy, ²San Raffaele Scientific Institute, Milan, Italy, ³Vita-Salute San Raffaele University, Milano, Italy, ⁴Vita-Salute San Raffaele University, Milan, Italy, ⁵Medicine and Clinical Immunology, San Raffaele Scientific Institute, Milan, Italy
Background/Purpose: No data comparing the long-term outcome of Adult-Onset Still’s Disease (AOSD) patients treated with different biological drugs is currently available. We evaluated the efficacy…
Abstract Number: 786 • 2013 ACR/ARHP Annual Meeting
Antibodies Against Drp-4 and Macropain Subunit C2 As a Potential Marker Of Aosd
Niklas T. Baerlecken¹, Nils Pursche², Torsten Witte³, Reinhold E. Schmidt¹, Marius Hoepfner¹, Frank Moosig⁴, Wolfgang L. Gross⁵, Eugen Feist⁶ and Dirk Foell⁷, ¹Clinical Immunology and Rheumatology, Medical University Hannover, Hannover, Germany, ²Clinical Immunology and Rheumatology, Medical University of Hannover, Hannover, Germany, ³Clinical Immunology and Rheumatology, Medical University Hannover, Hanover, Germany, ⁴Vasculitis Clinic, Klinikum Bad Bramstedt & University Hospital of Schleswig Holstein, Bad Bramstedt, Germany, ⁵Dept of Clinical Rheumatology, Medical University at Lubeck, Lubeck, Germany, ⁶Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany, ⁷Department of Pediatric Rheumatology and Immunology, University of Muenster, Muenster, Germany
Background/Purpose: Making the diagnosis of adult-onset Still's disease (AOSD) is mainly based on the exclusion of inflammatory, infectious and malignant diseases. There are no specific…
Abstract Number: 217 • 2013 ACR/ARHP Annual Meeting
Clinical Value Of ¹⁸f-Fluoro-Dexoxyglucose Positron Emission Tomography In Patients With Adult-Onset Still’s Disease
Hiroyuki Yamashita¹, Kazuo Kubota², Yuko Takahashi¹, Hiroshi Kaneko¹, Toshikazu Kano¹ and Akio Mimori¹, ¹Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan, ²Department of Radiology, National Center for Global Health and Medicine, Tokyo, Japan
AbstractBackground/Purpose: The aim of this study was to assess the usefulness of 18F-fluoro-dexoxyglucose positron emission tomography/Computed tomography (18F-FDG PET/CT) for the diagnosis or the evaluation…
Abstract Number: 191 • 2012 ACR/ARHP Annual Meeting
Analysis of Genes Involved in Autoinflammatory Diseases in Adult Onset Still’s Disease
Emma Garcia-Melchor¹, Dolors Grados², Eva Gonzalez-Roca¹, Elena Riera³, Manel Juan¹, Jordi Yagüe¹, Juan Ignacio Aróstegui¹, Javier Narváez⁴ and Alejandro Olivé⁵, ¹Immunology Department, Hospital Clinic Barcelona, Barcelona, Spain, ²Rheumatology Department, Hospital Universitario Germans Trias i Pujol, Badalona, Spain, ³Rheumatology Department, Hospital Mutua de Terrassa, Terrassa, Spain, ⁴Rheumatology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain, ⁵Rheumatology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain
Background/Purpose: Adult Onset Still’s Disease (AOSD) is a systemic inflammatory disease characterized by fever, skin rash, articular involvement, lymphadenopathy, hepatosplenomegaly and serositis. Due to the…
Abstract Number: 1063 • 2012 ACR/ARHP Annual Meeting
Dysfunction of Natural Killer and Natural Killer T Cells in Patients with Adult Onset Still’s Disease
Young-Nan Cho¹, Sung-Ji Lee¹, Tae-Jong Kim², Hye-Mi Jin¹, Dong-Jin Park², Seung-Jung Kee³ and Yong-Wook Park¹, ¹Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea, ²Rheumatology, Chonnam National University Medical School, Gwangju, South Korea, ³Laboratory Medicine, Chonnam National University Medical School and Hospital, Gwangju, South Korea
Background/Purpose: Adult onset Still’s disease (AOSD) is an uncommon systemic inflammatory disorder of unknown etiology. Natural killer (NK) cell dysfunction is frequently observed in some…
Abstract Number: 2250 • 2012 ACR/ARHP Annual Meeting
A Clinical Analysis of Adult Patients with Autoimmune- and Infection-Associated Hemophagocytic Lymphohistiocytosis
Min W. So¹, Bon S. Koo¹, You J. Kim¹, Yong-G Kim¹, Wook J. Seo², Chang-K Lee¹ and Bin Yoo¹, ¹Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, ²Internal Medicine, Seoul Veterans Hospital, Seoul, South Korea
Background/Purpose: Hemophagocytic lymphohistiocytosis (HLH) is a rare but potentially life-threatening disease. Secondary HLH is associated with various clinical conditions, including infections, malignancies, and autoimmune diseases.…